Pilar García-Alfonso

20PUBLICATIONS
100CO-AUTHORS
Molecular targetsChemotherapyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Feb 20, 2026
Axitinib and Long-Acting Octreotide in Advanced Extrapancreatic Neuroendocrine Tumors: A Randomized, Double-Blind, Placebo-Controlled, Phase III Clinical Trial (AXINET, GETNE 1107).

Rocio Garcia-Carbonero, Marta Benavent, Paula Jimenez-Fonseca

|Sep 30, 2025
Budget impact analysis of new drugs in oncology and haematology: Principles and practice.

Javier Soto-Alsar, José L Revuelta-Herrero, Cristina Villanueva-Bueno

|Aug 12, 2025
Definition of lines of treatment in metastatic colorectal cancer: a Delphi consensus.

Pilar García-Alfonso, Julia Alcaide-Garcia, Enrique Aranda Aguilar

|Nov 23, 2024
Trilaciclib prior to FOLFOXIRI/bevacizumab for patients with untreated metastatic colorectal cancer: phase 3 PRESERVE 1 trial.

Heinz-Josef Lenz, Tianshu Liu, Emerson Y Chen

|Jun 04, 2024
Lenvatinib Plus Pembrolizumab Versus Standard of Care for Previously Treated Metastatic Colorectal Cancer: Final Analysis of the Randomized, Open-Label, Phase III LEAP-017 Study.

Akihito Kawazoe, Rui-Hua Xu, Pilar García-Alfonso

|Feb 27, 2024
Delphi consensus for the third-line treatment of metastatic colorectal cancer.

Pilar García-Alfonso, Ruth Vera, Enrique Aranda

Pageof 4

Frequent Collaborators

5 joint publications

Andrés Muñoz-Martín

2 joint publications

Paula Jiménez-Fonseca

2 joint publications

Enrique Aranda

2 joint publications

Rocío Garcia-Carbonero